Pt | Sex | Age (yrs) | 1st Dose (mg) | 2nd Dose (mg) | 3rd Dose (mg) | Total rFVIIa (μg/kg) | Procedure* | Death | Cause of Death | TE episode | Associated Risk Factors |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 51 | 7.2 | 4.8 | - | 143 | VAD to OHT | Y | Graft Failure | N | N |
2 | M | 53 | 2.4 | - | - | 24 | VAD to OHT | N | - | N | N |
3 | M | 42 | 2.4 | - | - | 36 | VAD | N | - | Y (ATΨ) | N |
4 | M | 52 | 4.8 | 4.8 | - | 77 | VAD to OHT | Y | CVA** (embolic) | Y | Atherosclerosis |
5 | M | 61 | 2.4 | 1.2 | - | 36 | VAD | N | - | N | HIT^ |
6 | M | 64 | 4.8 | - | - | 72 | VAD to OHT | N | - | N | N |
7 | M | 62 | 4.8 | - | - | 56 | VAD to OHT | N | - | Y (DVT)Â¥ | N |
8 | M | 53 | 2.4 | 2.4 | 1.2 | 80 | VAD | Y | CVA (air embolism) | ? | N |
9 | M | 57 | 2.4 | 2.4 | 1.2 | 71 | OHT | N | - | N | N |
10 | M | 53 | 4.8 | - | - | 48 | VAD to OHT | N | - | N | N |
11 | F | 38 | 1.2 | 1.2 | - | 32 | VAD to OHT | N | - | N | N |
12 | F | 51 | 2.4 | 6 | 6 | 189 | VAD | Y | CVA (embolic) | Y | HIT^ |
13 | F | 67 | 4.8 | 2.4 | - | 109 | VAD | Y | Heart Failure | N | Y (Multiorgan failure), ABIOMED# |
14 | F | 46 | 4.8 | 4.8 | 1.2 | 150 | VAD to OHT | N | - | N | N |
15 | M | 49 | 4.8 | - | - | 49 | VAD to OHT | N | - | N | N |